These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 39173286)

  • 1. Progress of ATM inhibitors: Opportunities and challenges.
    Du S; Liang Q; Shi J
    Eur J Med Chem; 2024 Nov; 277():116781. PubMed ID: 39173286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of ataxia telangiectasia mutated kinase inhibitors.
    Andrs M; Korabecny J; Nepovimova E; Jun D; Hodny Z; Moravcova S; Hanzlikova H; Kuca K
    Mini Rev Med Chem; 2014; 14(10):805-11. PubMed ID: 25138084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small Molecular Inhibitors That Target ATM for Drug Discovery: Current Research and Potential Prospective.
    Qian C; Li X; Zhang J; Wang Y
    J Med Chem; 2024 Sep; 67(17):14742-14767. PubMed ID: 39149790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Characterization of Quinoline-3-Carboxamide Derivatives as Inhibitors of the ATM Kinase.
    Ravi S; Barui S; Kirubakaran S; Duhan P; Bhowmik K
    Curr Top Med Chem; 2020; 20(23):2070-2079. PubMed ID: 32735523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Novel 3-Quinoline Carboxamides as Potent, Selective, and Orally Bioavailable Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase.
    Degorce SL; Barlaam B; Cadogan E; Dishington A; Ducray R; Glossop SC; Hassall LA; Lach F; Lau A; McGuire TM; Nowak T; Ouvry G; Pike KG; Thomason AG
    J Med Chem; 2016 Jul; 59(13):6281-92. PubMed ID: 27259031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia-mutated kinase-mediated DNA damage response.
    Huang CY; Hsieh FS; Wang CY; Chen LJ; Chang SS; Tsai MH; Hung MH; Kuo CW; Shih CT; Chao TI; Chen KF
    Eur J Cancer; 2018 Oct; 102():10-22. PubMed ID: 30103095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of ATR selectively sensitizes ATM-deficient human mammary epithelial cells to ionizing radiation and DNA-damaging agents.
    Cui Y; Palii SS; Innes CL; Paules RS
    Cell Cycle; 2014; 13(22):3541-50. PubMed ID: 25483091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensors and Inhibitors for the Detection of Ataxia Telangiectasia Mutated (ATM) Protein Kinase.
    Huang C; Filippone NR; Reiner T; Roberts S
    Mol Pharm; 2021 Jul; 18(7):2470-2481. PubMed ID: 34125542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recently emerging signaling landscape of ataxia-telangiectasia mutated (ATM) kinase.
    Farooqi AA; Attar R; Arslan BA; Romero MA; ul Haq MF; Qadir MI
    Asian Pac J Cancer Prev; 2014; 15(16):6485-8. PubMed ID: 25169474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models.
    Durant ST; Zheng L; Wang Y; Chen K; Zhang L; Zhang T; Yang Z; Riches L; Trinidad AG; Fok JHL; Hunt T; Pike KG; Wilson J; Smith A; Colclough N; Reddy VP; Sykes A; Janefeldt A; Johnström P; Varnäs K; Takano A; Ling S; Orme J; Stott J; Roberts C; Barrett I; Jones G; Roudier M; Pierce A; Allen J; Kahn J; Sule A; Karlin J; Cronin A; Chapman M; Valerie K; Illingworth R; Pass M
    Sci Adv; 2018 Jun; 4(6):eaat1719. PubMed ID: 29938225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM.
    Hickson I; Zhao Y; Richardson CJ; Green SJ; Martin NM; Orr AI; Reaper PM; Jackson SP; Curtin NJ; Smith GC
    Cancer Res; 2004 Dec; 64(24):9152-9. PubMed ID: 15604286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA Double-strand Break Signaling Is a Therapeutic Target in Head and Neck Cancer.
    Wu J; Galvan KJ; Bogard RD; Peterson CE; Shergill A; Crowe DL
    Anticancer Res; 2021 Nov; 41(11):5393-5403. PubMed ID: 34732408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a cell-based, high-throughput screening assay for ATM kinase inhibitors.
    Guo K; Shelat AA; Guy RK; Kastan MB
    J Biomol Screen; 2014 Apr; 19(4):538-46. PubMed ID: 24464432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical potential of ATM inhibitors.
    Lavin MF; Yeo AJ
    Mutat Res; 2020; 821():111695. PubMed ID: 32304909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells.
    Teng PN; Bateman NW; Darcy KM; Hamilton CA; Maxwell GL; Bakkenist CJ; Conrads TP
    Gynecol Oncol; 2015 Mar; 136(3):554-61. PubMed ID: 25560806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of human ATM kinase inhibition.
    Stakyte K; Rotheneder M; Lammens K; Bartho JD; Grädler U; Fuchß T; Pehl U; Alt A; van de Logt E; Hopfner KP
    Nat Struct Mol Biol; 2021 Oct; 28(10):789-798. PubMed ID: 34556870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of APE1 redox and ATM synergistically sensitize osteosarcoma cells to ionizing radiation by inducing ferroptosis.
    Xiao H; Jiang N; Zhang H; Wang S; Pi Q; Chen H; He X; Luo W; Lu Y; Deng Y; Zhong Z
    Int Immunopharmacol; 2024 Sep; 139():112672. PubMed ID: 39032469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective ATM inhibition augments radiation-induced inflammatory signaling and cancer cell death.
    Chiu LY; Sun Q; Zenke FT; Blaukat A; Vassilev LT
    Aging (Albany NY); 2023 Jan; 15(2):492-512. PubMed ID: 36656721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the phosphorylation of ATM contributes to radioresistance of glioma stem cells.
    Zhou W; Sun M; Li GH; Wu YZ; Wang Y; Jin F; Zhang YY; Yang L; Wang DL
    Oncol Rep; 2013 Oct; 30(4):1793-801. PubMed ID: 23846672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feedback regulation of methyl methanesulfonate and ultraviolet-sensitive gene clone 81 via ATM/Chk2 pathway contributes to the resistance of MCF-7 breast cancer cells to cisplatin.
    Lv J; Qian Y; Ni X; Xu X; Dong X
    Tumour Biol; 2017 Mar; 39(3):1010428317694307. PubMed ID: 28347251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.